Home » Topics » Regulatory » Patents

Patents
RSS

Novel Wnt signaling and IL-6 production inhibitors patented by Samumed

Feb. 22, 2017

Raze Therapeutics presents novel MTHFD2 inhibitors

Feb. 21, 2017

Vitae Pharmaceuticals discloses novel nuclear receptor ROR-gamma modulators

Feb. 21, 2017

Amgen discovers beta-secretase inhibitors

Feb. 21, 2017

Novel TNF-alpha antagonists synthesized at Bristol-Myers Squibb

Feb. 21, 2017

NantWorks/Nant Holdings patent thiosemicarbazone derivatives

Feb. 21, 2017

Samumed identifies novel Wnt signaling and IL-6 production inhibitors

Feb. 21, 2017

Progenra describes new USP7/USP47 inhibitors

Feb. 20, 2017

Toyama Chemical, Fujifilm identify novel C-X-C motif chemokine 10 inhibitors

Feb. 20, 2017

Allergan discloses new fMet-Leu-Phe/N-formyl peptide receptor 2 agonists

Feb. 17, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Pharma industry faces long haul to get return on investment from AI
BioWorld Science
Artificial intelligence tools are springing up at multiple points along drug discovery and development, but despite the hype, as yet there is minimal return on...